Effects of hormone replacement therapy on hemostatic cardiovascular risk factors

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 2 I, 1999, Pages 283-289

  Andersen, L F ^a   Gram, J ^a   Skouby, S O ^a   Jespersen, J ^a  

^a ESBJERG HOSPITAL   (Denmark)

Author keywords

Coagulation; Fibrinogen; Fibrinolysis; Ischemic heart disease; Menopause

Indexed keywords

BLOOD CLOTTING FACTOR 7; CYPROTERONE ACETATE; ESTRADIOL VALERATE; FIBRINOGEN; HEMOSTATIC AGENT; LIPOPROTEIN A; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT PLANNING;

EID: 0032964407     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70201-2     Document Type: Article

References (25)